Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Contrast Media | 4 | 2018 | 1011 | 1.36 | Why? |
| Cannula | 3 | 2020 | 750 | 1.16 | Why? |
| Drug Delivery Systems | 4 | 2019 | 1365 | 0.93 | Why? |
| Amikacin | 1 | 2019 | 62 | 0.77 | Why? |
| Cell Cycle Checkpoints | 1 | 2018 | 126 | 0.72 | Why? |
| Iodine | 1 | 2017 | 116 | 0.59 | Why? |
| Speech | 1 | 2018 | 241 | 0.58 | Why? |
| Acute Kidney Injury | 4 | 2018 | 5762 | 0.55 | Why? |
| Patient Positioning | 2 | 2021 | 1505 | 0.52 | Why? |
| Bronchodilator Agents | 1 | 2019 | 444 | 0.52 | Why? |
| Prone Position | 2 | 2021 | 1861 | 0.49 | Why? |
| Administration, Inhalation | 4 | 2020 | 1647 | 0.47 | Why? |
| Nebulizers and Vaporizers | 4 | 2019 | 497 | 0.45 | Why? |
| Iohexol | 2 | 2019 | 42 | 0.39 | Why? |
| Purpura Fulminans | 2 | 2019 | 22 | 0.39 | Why? |
| Blood Pressure Determination | 3 | 2017 | 450 | 0.37 | Why? |
| Aerosols | 8 | 2020 | 5393 | 0.35 | Why? |
| Respiratory Insufficiency | 4 | 2021 | 7301 | 0.30 | Why? |
| Oxygen Inhalation Therapy | 4 | 2020 | 3629 | 0.24 | Why? |
| Critical Illness | 6 | 2020 | 17281 | 0.24 | Why? |
| Lung | 4 | 2019 | 31049 | 0.23 | Why? |
| Critical Care | 5 | 2018 | 14081 | 0.23 | Why? |
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 102 | 0.20 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.20 | Why? |
| Communication | 1 | 2018 | 5206 | 0.20 | Why? |
| Metabolic Clearance Rate | 1 | 2019 | 110 | 0.20 | Why? |
| Renal Dialysis | 1 | 2017 | 4358 | 0.20 | Why? |
| Cross-Over Studies | 2 | 2020 | 867 | 0.19 | Why? |
| Wakefulness | 2 | 2021 | 598 | 0.19 | Why? |
| Intensive Care Units | 7 | 2019 | 29594 | 0.19 | Why? |
| Natural Killer T-Cells | 1 | 2020 | 191 | 0.19 | Why? |
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2018 | 45 | 0.19 | Why? |
| Inhalation | 1 | 2019 | 86 | 0.19 | Why? |
| Mucosal-Associated Invariant T Cells | 1 | 2020 | 170 | 0.18 | Why? |
| Technetium Tc 99m Pentetate | 1 | 2017 | 14 | 0.18 | Why? |
| Blood Pressure Monitors | 1 | 2017 | 28 | 0.18 | Why? |
| Models, Anatomic | 1 | 2019 | 191 | 0.17 | Why? |
| Sodium Bicarbonate | 1 | 2017 | 54 | 0.17 | Why? |
| Kidney Function Tests | 1 | 2019 | 520 | 0.17 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.16 | Why? |
| Intubation | 1 | 2019 | 437 | 0.16 | Why? |
| Models, Animal | 1 | 2019 | 788 | 0.15 | Why? |
| Ireland | 1 | 2021 | 1456 | 0.15 | Why? |
| Inhalation Exposure | 1 | 2020 | 405 | 0.15 | Why? |
| Noninvasive Ventilation | 2 | 2019 | 2329 | 0.15 | Why? |
| Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 279 | 0.14 | Why? |
| Infusions, Intravenous | 1 | 2019 | 1224 | 0.14 | Why? |
| Trachea | 1 | 2019 | 894 | 0.13 | Why? |
| Tomography, X-Ray Computed | 2 | 2018 | 25144 | 0.13 | Why? |
| Arterial Pressure | 1 | 2015 | 208 | 0.13 | Why? |
| Equipment Design | 3 | 2019 | 3095 | 0.13 | Why? |
| Ventilator Weaning | 1 | 2018 | 536 | 0.13 | Why? |
| Creatinine | 1 | 2019 | 1443 | 0.12 | Why? |
| Mexico | 1 | 2021 | 2787 | 0.12 | Why? |
| Administration, Intravenous | 1 | 2017 | 1115 | 0.12 | Why? |
| Cardiovascular Surgical Procedures | 1 | 2015 | 281 | 0.11 | Why? |
| Respiration, Artificial | 4 | 2020 | 22116 | 0.10 | Why? |
| Hydrocortisone | 1 | 2020 | 1790 | 0.10 | Why? |
| Swine | 1 | 2019 | 3352 | 0.10 | Why? |
| France | 3 | 2021 | 12074 | 0.10 | Why? |
| Postoperative Care | 1 | 2015 | 755 | 0.10 | Why? |
| Phenotype | 1 | 2020 | 4037 | 0.10 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.10 | Why? |
| Hypoxia | 2 | 2020 | 3626 | 0.09 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.09 | Why? |
| Canada | 1 | 2021 | 6018 | 0.09 | Why? |
| Oscillometry | 2 | 2017 | 50 | 0.09 | Why? |
| Bayes Theorem | 1 | 2017 | 3237 | 0.08 | Why? |
| Humans | 26 | 2021 | 930598 | 0.08 | Why? |
| Survivors | 1 | 2019 | 2619 | 0.08 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.08 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.08 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.08 | Why? |
| Anti-Infective Agents | 1 | 2018 | 1766 | 0.08 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.07 | Why? |
| Renal Insufficiency, Chronic | 1 | 2019 | 2654 | 0.07 | Why? |
| Hypotension | 2 | 2017 | 392 | 0.07 | Why? |
| Arrhythmias, Cardiac | 1 | 2017 | 2510 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Spain | 1 | 2021 | 15545 | 0.06 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.06 | Why? |
| Adult | 7 | 2021 | 244371 | 0.05 | Why? |
| Equivalence Trials as Topic | 1 | 2020 | 242 | 0.05 | Why? |
| Antigens, Differentiation, T-Lymphocyte | 1 | 2020 | 146 | 0.05 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.05 | Why? |
| Animals | 2 | 2019 | 78931 | 0.05 | Why? |
| Male | 12 | 2021 | 367725 | 0.05 | Why? |
| Aged | 7 | 2021 | 215776 | 0.05 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.05 | Why? |
| Retreatment | 1 | 2018 | 186 | 0.04 | Why? |
| Female | 11 | 2021 | 380317 | 0.04 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.04 | Why? |
| Lectins, C-Type | 1 | 2020 | 405 | 0.04 | Why? |
| Manometry | 1 | 2017 | 91 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Early Termination of Clinical Trials | 1 | 2020 | 1256 | 0.04 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.04 | Why? |
| Hemodynamic Monitoring | 1 | 2017 | 61 | 0.04 | Why? |
| Arm | 1 | 2017 | 159 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
| Catheterization | 1 | 2019 | 264 | 0.04 | Why? |
| Neisseria meningitidis | 1 | 2018 | 229 | 0.04 | Why? |
| Infant | 1 | 2019 | 30274 | 0.04 | Why? |
| Amputation | 1 | 2018 | 331 | 0.04 | Why? |
| Sodium Chloride | 1 | 2017 | 203 | 0.04 | Why? |
| Tissue Distribution | 1 | 2017 | 483 | 0.04 | Why? |
| Meningococcal Infections | 1 | 2018 | 216 | 0.04 | Why? |
| Antigens, CD | 1 | 2020 | 984 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.04 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.03 | Why? |
| Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 341 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Catheterization, Peripheral | 1 | 2017 | 249 | 0.03 | Why? |
| United States | 1 | 2021 | 46150 | 0.03 | Why? |
| Oximetry | 1 | 2019 | 658 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2020 | 1289 | 0.03 | Why? |
| Airway Extubation | 1 | 2018 | 403 | 0.03 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.03 | Why? |
| Aged, 80 and over | 3 | 2019 | 88759 | 0.03 | Why? |
| Administration, Intranasal | 1 | 2017 | 1132 | 0.03 | Why? |
| Nose | 1 | 2019 | 1093 | 0.03 | Why? |
| Pneumococcal Infections | 1 | 2018 | 562 | 0.03 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.03 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2020 | 10649 | 0.03 | Why? |
| Child | 1 | 2019 | 70012 | 0.02 | Why? |
| Cells, Cultured | 1 | 2020 | 5835 | 0.02 | Why? |
| Double-Blind Method | 1 | 2020 | 5988 | 0.02 | Why? |
| Shock, Septic | 1 | 2018 | 1313 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2017 | 1956 | 0.02 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.02 | Why? |
| Hypertension | 2 | 2017 | 8895 | 0.02 | Why? |
| Decision Making | 1 | 2020 | 3132 | 0.02 | Why? |
| Hospital Mortality | 2 | 2018 | 22087 | 0.02 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.02 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2019 | 3962 | 0.02 | Why? |
| Young Adult | 3 | 2019 | 93724 | 0.02 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Adolescent | 1 | 2019 | 86841 | 0.01 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.00 | Why? |
Ehrmann's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(152)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(188)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_